Can decentralized and agile approaches also be applied to LTFUs and the collection of real-world evidence (RWE)? What does that look like, who’s interested in pursuing it, and what are the perceived benefits and pitfalls?
https://www.pharmalive.com/wp-content/uploads/2021/12/Getting-real-with-real-world-evidence-Logo.png1601064Administratorhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAdministrator2022-08-09 15:16:502022-08-10 09:16:38Using decentralized approaches to unleash the power of real-world evidence in long-term follow-up studies